John Edward Park

Person

Warthausen, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Methods of treating asthma with polypeptides targeting IL-13 and TSLP
- Patent number 11,840,566
- Issue date Dec 12, 2023
- Ablynx N.V.
- Heidi Rommelaere
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Recombinant rhabdovirus encoding for CCL21
- Patent number 11,707,495
- Issue date Jul 25, 2023
- Boehringer Ingelheim International GmbH
- Philipp Mueller
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Polypeptides comprising immunoglobulin single variable domains targ...
- Patent number 11,208,476
- Issue date Dec 28, 2021
- Ablynx N.V.
- Heidi Rommelaere
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Medicaments for the treatment or prevention of fibrotic diseases
- Patent number 10,154,990
- Issue date Dec 18, 2018
- Boehringer Ingelheim International GmbH
- John Edward Park
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
A-beta binding polypeptides
- Patent number 9,211,330
- Issue date Dec 15, 2015
- Ablynx N.V.
- John E. Park
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of using antibodies during anticoagulant therapy of dabigat...
- Patent number 9,034,822
- Issue date May 19, 2015
- Boehringer Igelheim International GmbH
- Joanne Van Ryn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monoclonal antibodies that bind to HGM-CSF and medical compositions...
- Patent number 8,679,502
- Issue date Mar 25, 2014
- Evec Inc.
- Kenzo Takada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Nucleic acid molecules encoding A-beta binding polypeptides
- Patent number 8,614,308
- Issue date Dec 24, 2013
- Boehringer Ingelheim International GmbH
- John E. Park
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anticoagulant antidotes comprising antibodies that bind dabigatran...
- Patent number 8,486,398
- Issue date Jul 16, 2013
- Boehringer Ingelheim International GmbH
- Joanne Van Ryn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
A-beta binding polypeptides
- Patent number 8,337,845
- Issue date Dec 25, 2012
- Boehringer Ingelheim International GmbH
- John E. Park
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated proteins containing portions of FAPα and other proteins
- Patent number 6,846,910
- Issue date Jan 25, 2005
- Ludwig Institute for Cancer Research
- Rainer Zimmermann
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
FAP-activated anti-tumour compounds
- Patent number 6,613,879
- Issue date Sep 2, 2003
- Boehringer Ingelheim Pharma KG
- Raymond A. Firestone
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FAPα-specific antibody with improved producibility
- Patent number 6,455,677
- Issue date Sep 24, 2002
- Boehringer Ingelheim International GmbH
- John Edward Park
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated dimeric fibroblast activation protein .alpha., and uses th...
- Patent number 5,965,373
- Issue date Oct 12, 1999
- Ludwig Institute for Cancer Research
- Rainer Zimmermann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isolated dimeric fibroblast activation protein alpha, and uses thereof
- Patent number 5,767,242
- Issue date Jun 16, 1998
- Boehringer Ingelheim Int'l GmbH
- Rainer Zimmermann
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
VIRAL VECTORS AND NUCLEIC ACIDS FOR REGULATED GENE THERAPY
- Publication number 20240076689
- Publication date Mar 7, 2024
- Boehringer Ingelheim International GmbH
- John Park
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT RHABDOVIRUS ENCODING FOR CCL21
- Publication number 20240000874
- Publication date Jan 4, 2024
- Boehringer Ingelheim International GmbH
- Philipp MUELLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
- Publication number 20230372297
- Publication date Nov 23, 2023
- Boehringer Ingelheim International GmbH
- John Edward PARK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARG...
- Publication number 20220177565
- Publication date Jun 9, 2022
- Ablynx N.V.
- Heidi Rommelaere
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARG...
- Publication number 20220177564
- Publication date Jun 9, 2022
- Ablynx N.V.
- Heidi Rommelaere
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARG...
- Publication number 20220177566
- Publication date Jun 9, 2022
- Ablynx N.V.
- Heidi Rommelaere
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARG...
- Publication number 20220153854
- Publication date May 19, 2022
- Ablynx N.V.
- Heidi Rommelaere
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARG...
- Publication number 20210214431
- Publication date Jul 15, 2021
- Ablynx N. V.
- Heidi Rommelaere
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARG...
- Publication number 20210188965
- Publication date Jun 24, 2021
- Ablynx N.V.
- Heidi Rommelaere
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
- Publication number 20200330435
- Publication date Oct 22, 2020
- Boehringer Ingelheim International GmbH
- John Edward PARK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT RHABDOVIRUS ENCODING FOR CCL21
- Publication number 20200237838
- Publication date Jul 30, 2020
- Boehringer Ingelheim International GmbH
- Philipp MUELLER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DEISEASES
- Publication number 20190038600
- Publication date Feb 7, 2019
- Boehringer Ingelheim International GmbH
- John Edward PARK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
- Publication number 20160136133
- Publication date May 19, 2016
- Boehringer Ingelheim International GmbH
- John Edward PARK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTICOAGULANT ANTIDOTES
- Publication number 20150210778
- Publication date Jul 30, 2015
- Boehringer Ingelheim International GmbH
- Joanne VAN RYN
- G01 - MEASURING TESTING
Information Patent Application
MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
- Publication number 20140296217
- Publication date Oct 2, 2014
- Boehringer Ingelheim International GmbH
- John Edward PARK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES THAT BIND TO HGM-CSF AND MEDICAL COMPOSITIONS...
- Publication number 20140205611
- Publication date Jul 24, 2014
- Boehringer Ingelheim International GmbH
- Kenzo Takada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
- Publication number 20140128409
- Publication date May 8, 2014
- Boehringer Ingelheim International GmbH
- John Edward PARK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A-BETA BINDING POLYPEPTIDES
- Publication number 20140030275
- Publication date Jan 30, 2014
- Boehringer Ingelheim International GmbH
- John E. PARK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTICOAGULANT ANTIDOTES
- Publication number 20130289248
- Publication date Oct 31, 2013
- Boehringer Ingelheim International GmbH
- Joanne VAN RYN
- G01 - MEASURING TESTING
Information Patent Application
A-BETA BINDING POLYPEPTIDES
- Publication number 20130017209
- Publication date Jan 17, 2013
- Boehringer Ingelheim International GmbH
- John E. PARK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A-BETA BINDING POLYPEPTIDES
- Publication number 20120058118
- Publication date Mar 8, 2012
- Boehringer Ingelheim International GmbH
- John E. PARK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTICOAGULANT ANTIDOTES
- Publication number 20120027780
- Publication date Feb 2, 2012
- Boehringer Ingelheim International GmbH
- Joanne Van Ryn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
- Publication number 20120004202
- Publication date Jan 5, 2012
- Boehringer Ingelheim International GmbH
- John Edward PARK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES THAT BIND TO HGM-CSF AND MEDICAL COMPOSITIONS...
- Publication number 20110182905
- Publication date Jul 28, 2011
- Evec Inc.
- Kenzo Takada
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE PROCESSES
- Publication number 20110076238
- Publication date Mar 31, 2011
- Boehringer Ingelheim International GmbH
- John Edward PARK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
- Publication number 20100204211
- Publication date Aug 12, 2010
- Boehringer Ingelheim International GmbH
- John Edward PARK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
- Publication number 20090048267
- Publication date Feb 19, 2009
- Boehringer Ingelheim International GmbH
- John Edward PARK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Medicaments for the Treatment or Prevention of Fibrotic Diseases
- Publication number 20060154939
- Publication date Jul 13, 2006
- Boehringer Ingelheim International GmbH
- John Edward Park
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Medicaments for the Treatment or Prevention of Fibrotic Diseases
- Publication number 20060148883
- Publication date Jul 6, 2006
- Boehringer Ingelheim International GmbH
- John Edward Park
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Medicaments for the Treatment or Prevention of Fibrotic Diseases
- Publication number 20060142373
- Publication date Jun 29, 2006
- Boehringer Ingelheim International GmbH
- John Edward Park
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

John Edward Park

Person

Patents Grantslast 30 patents

Methods of treating asthma with polypeptides targeting IL-13 and TSLP

Recombinant rhabdovirus encoding for CCL21

Polypeptides comprising immunoglobulin single variable domains targ...

Medicaments for the treatment or prevention of fibrotic diseases

A-beta binding polypeptides

Methods of using antibodies during anticoagulant therapy of dabigat...

Monoclonal antibodies that bind to HGM-CSF and medical compositions...

Nucleic acid molecules encoding A-beta binding polypeptides

Anticoagulant antidotes comprising antibodies that bind dabigatran...

A-beta binding polypeptides

Isolated proteins containing portions of FAPα and other proteins

FAP-activated anti-tumour compounds

FAP&#x03B1;-specific antibody with improved producibility

Isolated dimeric fibroblast activation protein .alpha., and uses th...

Isolated dimeric fibroblast activation protein alpha, and uses thereof

Patents Applicationslast 30 patents

VIRAL VECTORS AND NUCLEIC ACIDS FOR REGULATED GENE THERAPY

RECOMBINANT RHABDOVIRUS ENCODING FOR CCL21

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARG...

POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARG...

POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARG...

POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARG...

POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARG...

POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARG...

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

RECOMBINANT RHABDOVIRUS ENCODING FOR CCL21

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DEISEASES

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

ANTICOAGULANT ANTIDOTES

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

MONOCLONAL ANTIBODIES THAT BIND TO HGM-CSF AND MEDICAL COMPOSITIONS...

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

A-BETA BINDING POLYPEPTIDES

ANTICOAGULANT ANTIDOTES

A-BETA BINDING POLYPEPTIDES

A-BETA BINDING POLYPEPTIDES

ANTICOAGULANT ANTIDOTES

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

MONOCLONAL ANTIBODIES THAT BIND TO HGM-CSF AND MEDICAL COMPOSITIONS...

COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE PROCESSES

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

Medicaments for the Treatment or Prevention of Fibrotic Diseases

Medicaments for the Treatment or Prevention of Fibrotic Diseases

Medicaments for the Treatment or Prevention of Fibrotic Diseases

FAPα-specific antibody with improved producibility